U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

BETHANIDINE C-14

MORE DETAILS

V57OVW9EIR

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

BETHANIDINE

MORE DETAILS

  W8S3YM7AUU

Status:
US Previously Marketed
Source:
TENATHAN by ROBINS AH
(1981)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017675
First approved in 1981
Source:
TENATHAN by ROBINS AH
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017675
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
adrenergic receptor signaling pathway involved in heart process
2
Conditions:
Hypertension
567
Bethanidine is a post-ganglionic adrenergic neurone-blocking agent which exerts a marked postural hypotensive effect. The precise mechanism whereby bethanidine causes blockade of adrenergic neurones is unknown. An initial sympathomimetic effect has been demonstrated in man and animals, possibly due to release of catecholamines.

BETHANIDINE SULFATE C-14

MORE DETAILS

4PF307C50Z

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

BETHANIDINE SULFATE

MORE DETAILS

  J4THI5N7O2

Status:
US Previously Marketed
Source:
TENATHAN by ROBINS AH
(1981)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017675
First approved in 1981
Source:
TENATHAN by ROBINS AH
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017675
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
adrenergic receptor signaling pathway involved in heart process
2
Conditions:
Hypertension
567
Bethanidine is a post-ganglionic adrenergic neurone-blocking agent which exerts a marked postural hypotensive effect. The precise mechanism whereby bethanidine causes blockade of adrenergic neurones is unknown. An initial sympathomimetic effect has been demonstrated in man and animals, possibly due to release of catecholamines.
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966